79.25 USD
↘ 2.18 (2.68%)AT CLOSE (03:59 PM EDT)
Mirum Pharmaceuticals, Inc. Common Stock
MIRMNASDAQ • USD
79.22
↘ 0.03 (0.04%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
79.22
↘ 0.03 (0.04%)
Market: OPEN
MIRM is currently priced at $79.22. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (8253.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, MIRM trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 5, 2026.
Open?$81.94
High?$81.94
Low?$77.78
Prev. Close?$81.43
Volume?1.1M
Avg. Volume?697.3K
VWAP?$79.37
Rel. Volume?1.64x
Bid / Ask
Bid?$55.04 × 100
Ask?$91.20 × 100
Spread?$36.16
Midpoint?$73.12
Valuation & Ratios
Market Cap?5.3B
Shares Out?64.9M
Float?50.3M
Float %?77.4%
P/E Ratio?N/A
P/B Ratio?-507.33
EPS?-$13.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Employees
433
Market Cap
5.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-07-18
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY, CA 94404
Phone: 650-667-4085
FOSTER CITY, CA 94404
Phone: 650-667-4085
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?1
Momentum?83
Short Sent.?48
Piotroski F-Score?2/9Weak
Altman Z-Score?-0.60Distress
Confidence?55%Low
Short InterestVery High
Short % of Float?12.50%High
Short Interest?6.3M
Days to Cover?12.0
Free Float50.3M
Avg Daily Volume523.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.86Strong
Quick Ratio?2.74Strong
Cash Ratio?1.48Strong
Debt/Equity?-71.97Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-507.33CHEAP▾
S&P97
P/S?8.55HIGH▾
Peers100
S&P11
P/FCF?N/A▾
EV/EBITDA?-7.1CHEAP▾
S&P97
EV/Sales?9.23HIGH▾
Peers100
S&P13
Returns & Efficiency
ROE?8,253.8%STRONG▾
Peers50
S&P97
ROA?-82.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-228741000
Enterprise Value?$5.7B
Fundamentals ratios updated end of day